Dispenser for dispensing a fluid into a nasal cavity
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Claims
The ornamental design for a dispenser for dispensing a fluid into a nasal cavity, as shown and described.
D176226 | November 1955 | Morris |
D251203 | February 27, 1979 | Williamson |
D414261 | September 21, 1999 | Ritsche |
D438459 | March 6, 2001 | Holthaus |
D447230 | August 28, 2001 | Matsugi et al. |
6745760 | June 8, 2004 | Grychowski et al. |
D498681 | November 23, 2004 | Fenton et al. |
D527640 | September 5, 2006 | Cummings et al. |
D527817 | September 5, 2006 | Ziegler et al. |
20060137683 | June 29, 2006 | Anderson et al. |
Type: Grant
Filed: Nov 6, 2006
Date of Patent: Oct 2, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Henlow), Hugh Alexander Connell (Evesham), Michael Birsha Davies (Ware), Andrew Robert Gibbs (Leamington Spa), Paul Kenneth Rand (Ware), Robert William Tansley (Bidford on Avon)
Primary Examiner: Ian Simmons
Assistant Examiner: W. Laymon
Attorney: James P. Riek
Application Number: 29/250,183